Methods for treating tauopathy
US10004753B2 · kind B2 · utility
0Cited by
22References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2016 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Jan 15, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6933
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides methods of reducing the level of acetylated Tau in a neuron or a glial cell in an individual, the methods involving administering to the individual a prodrug that is converted in the individual to salicylate. The present disclosure provides methods of treating a tauopathy in an individual, the methods involving administering to the individual a prodrug that is converted in the individual to salicylate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.